Amgen Inc. buy BMO Capital Markets
Start price
03.12.25
/
50%
€288.65
Target price
03.12.26
-
Performance (%)
13.88%
Price
11:53
€326.20
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 13.88%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 03.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.107% | 0.107% |
| iShares Core DAX® | -2,53 % | -5,19 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % |
| iShares S&P 500 | -0,80 % | 0,16 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for AMGN provided by MarketBeat